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IN ABSORPTIVE AND SECRETORY epithelia, K ϩ channels play a major role in maintaining an electrochemical gradient necessary for Na ϩ and Cl Ϫ transepithelial transport. Na ϩ reabsorption and Cl Ϫ secretion are important processes in airway epithelial cells. Although the molecular identities of the ion channels and transporters involved in Na ϩ and Cl Ϫ transport [like the epithelial sodium channel (ENaC) and the cystic fibrosis transmembrane regulator (CFTR), NaK2Cl cotransporter, and Na ϩ -K ϩ -ATPase] are relatively well defined, very little is known about the molecular nature and physiological role of the system involved in K ϩ transport. The four principal classes of K ϩ channels are represented in nasal and lung epithelial cells (for review, see Refs. 12 and 46). Indeed, 1) multiple voltage-dependent K ϩ channels (including Kv1.1, 1.3, 1.4, 4.1-4.3, Kv9.3, and KvlQT1); 2) calciumactivated K ϩ channels (K Ca channels SK4 or Slo); 3) inwardly rectifying K ϩ channels [Kir2.1 (33) , Kir6.1 (K ATP channel), Kir7 (19) ]; and 4) four transmembrane domain K ϩ channels (Twik, Trek, Task) have been found to be expressed. Among all these K ϩ channels expressed in the lung, we know nothing about the functional role of several of them. In addition, the physiological relevance of the presence of so many K ϩ channels is still unclear. Nevertheless, a potential importance of KvLQT1, K Ca , and ATP-sensitive K ϩ (K ATP ) channels in transepithelial ion transport has been suggested.
KvLQT1 (1, 35, 53 ) is expressed at high levels in lung and nasal epithelial cells (15, 25, 43) . This small-conductance K ϩ channel (Ͻ3 pS, Ref. 54) , activated by cAMP and inhibited by clofilium, could play a role in Cl Ϫ secretion in nasal and bronchial cells (13, (41) (42) (43) , as well as in tracheal Na ϩ absorption (25) . Two types of K Ca channels seem to be present in the airways, one with intermediate conductance (IK Ca or SK4 subtype) detected in trachea and bronchial cells (13, 44, 55) , the other with high conductance (200 pS, maxi-K Ca or Slo1 subtype) reported in nasal cells and the alveolar A549 cell line (36, 37, 47) . Both of these K Ca channels could be important in Cl Ϫ secretion (16, 42, 50) . K ATP channels are formed from two different types of subunits: inwardly rectifying pore-forming subunits (Kir6.1 or 6.2) and sulfonylurea receptors (SUR1, 2A, or 2B). Kir6.1, cloned for the first time from a lung library (29) , was found to be expressed at a moderate level in the rat lung (30) , whereas Kir6.2 and SUR1, highly expressed in pancreatic islets, seem absent in the lung (28) . In addition, SUR2A is predominantly expressed in heart and skeletal muscle, whereas SUR2B is ubiquitously expressed, including in the lung (31) . Such distribution indicates that the lung epithelial K ATP channel could be formed from Kir6.1 and SUR2B subunits. However, the precise molecular identity and cellular localization of K ATP in the lung are unknown. In fact, although such a composition was predicted in the kidney, we have recently shown that the proximal tubule K ATP channel could be formed from the Kir6.1 plus SUR2A and/or SUR2B subunits (10) . K ATP channels are sensitive to ATP, inhibited by glibenclamide, and activated by diazoxide or pinacidil.
K ATP channels might have an important role in lung physiology and pathophysiology. Indeed, YM934, a K ATP channel opener, increases alveolar liquid clearance in the human lung (48) . This result indicates that K ATP activation might stimulate Na ϩ transport in the lung, since it is the main mechanism involved in alveolar liquid clearance (4) . K ATP channel openers, with a well-known protective effect against ischemiareperfusion injury in the heart, have also been shown to exert a beneficial action in the lungs (24, 34, 56) .
Because K ATP channels might have an important physiological impact on alveolar epithelial cell functions and in view of the dearth of knowledge on these channels in the lung, we decided to characterize their molecular identity and determine their physiological role in transepithelial transport in alveolar epithelial cells. We found that Kir6.1 and SUR2B are subunits that form the K ATP channel in alveolar cells, and its modulation has an impact on Na ϩ and Cl Ϫ transepithelial transport.
MATERIALS AND METHODS

Alveolar Epithelial Cell Isolation and Primary Culture
Alveolar epithelial type II cells (ATII) were isolated from male Sprague-Dawley rats according to a well-established protocol (23) and according to a procedure approved by the animal care and use committee of the institution. In brief, after anesthesia, tracheotomy, and cannulation of the pulmonary artery, the lungs were perfused to remove blood cells and simultaneously inflated with air. After retrieval from the thoracic cavity, they were washed 10 times to remove alveolar macrophages and treated subsequently with elastase. They were then minced, and the resulting suspensions were filtered. Alveolar cells were collected and purified by a differential adherence technique that enhances the purity of the ATII cell pool (17) . Briefly, "pre-IgG" cell suspensions were incubated for 45-60 min on bacteriological plastic plates coated with rat IgG at 37°C in a 5% CO 2 incubator. Most macrophages were bound to IgG, whereas nonadherent "post-IgG" cells were collected and recovered by centrifugation. Alkaline phosphatase staining, to identify ATII cells (21) , showed that the proportion of ATII cells of 69% in the pre-IgG mix increased to 86% in the post-IgG mix. This freshly isolated cell suspension was used directly for RNA extraction (day 0) or plated at 1 ϫ 10 6 cells/cm 2 on Transwell Costar permeant filters (4 cm 2 ) in MEM containing 10% FBS, 0.08 mg/l gentamicin, septra (3 g/ml trimethoprime ϩ 17 g/ml sulfamethoxazole), 0.2% NaHCO 3, 10 mM HEPES, and 2 mM L-glutamine and then cultured at 37°C with 5% CO 2 in a humidified incubator. The medium was replaced after 3 days by the same MEM without septra.
Molecular Biology
RNA purification. Total RNA from ATII cells (freshly isolated or cultured for 1-4 days on permeant filters) was purified with TRIzol reagent according to the manufacturer's instructions (Invitrogen, Burlington, Ontario, Canada).
PCR amplification of full-length KATP subunits. cDNAs were obtained with the Smart PCR cDNA synthesis kit (Clontech, Palo Alto, CA) from total RNAs purified from freshly isolated ATII cells. The multiple cDNA synthesis cycles of this protocol allow significant enrichment of full-length cDNA, a very appropriate tool, especially for long cDNAs such as SUR. Primers designed from the sequences of cloned rat Kir6. ) were used to amplify PCR products from ATII cell cDNAs with the Long Expand Long Template PCR System (Roche, Laval, Québec, Canada). The Kir6.1 primers (sense: 5Ј-ccgccatgctggccaggaagagcatcatcc3Ј, antisense: 5Јccctcatgattctgatgggcactggtttcc-3Ј) were designed to amplify a 1,283-bp product corresponding to full-length Kir6.1, whereas the Kir6.2 primers (sense: 5Ј-ccgccatgctgtcccgaaaaggcattatcc-3Ј, antisense: 5Ј-gcaactcaggacaaggaatccggagagatgc-3Ј) would amplify a 1,181-bp product corresponding to fulllength Kir6.2. For full-length SUR1 (4,760-bp), the following primers were deployed: sense: 5Ј-ccaccatgcctttggccttctgcggcaccg-3Ј, antisense: 5Ј-ggctggtcatttgtccgcgcggacaaagg-3Ј. The SUR2 primer pair (sense: 5Ј-ccgccatgagcctttccttctgtggtaac-3Ј, antisense: 5Ј-cctgtcacatgtccgcacgaacgaacgagg-3Ј) amplifies a 4.6-bp product corresponding to full-length SUR2A or SUR2B. Indeed, the 5Ј-ends of these two subunits are identical, and the selected sequence of the 3Ј-primer, corresponding to the 3Ј-end of SUR2B, is also present in the 3Ј-untranslated region of SUR2A. In fact, the nucleotide sequences of SUR2A and SUR2B are identical, apart from an insertion in the 3Ј-end of the coding region of SUR2A, which generates a COOH terminus different from SUR2B. Therefore, a different strategy was adopted to discriminate between the two isoforms (see below).
Semiquantitative PCR. Five micrograms of total RNA, purified from freshly isolated or cultured ATII cells, were reverse-transcribed to cDNA with Moloney murine leukemia virus reverse transcriptase (RT; Invitrogen, Burlington, Ontario, Canada) in the presence of oligo-dT primers. cDNAs were amplified with Taq polymerase (Invitrogen) using specific primers designed from sequences of cloned rat Kir6.1 and SUR2. The Kir6.1b primers (sense: 5Ј-cgcccacggggacatctatgc-3Ј, antisense: 5Ј-agggggctacgcttatcaat-3Ј, 1 M final concentration of each) were designed to amplify a 544-bp product. To discriminate between SUR2A and SUR2B, we employed a new pair of primers (sense: 5Ј-gcggatcgcacggttgtaaccatagctc-3Ј, antisense: 5Ј-cctgtcacatgtccgcacgaacgaacgagg-3Ј, 1 M final concentration of each) to encompass the 3Ј-insert region of SUR2A and, therefore, amplify products of different size for SUR2A (343 bp) or SUR2B (169 bp). The ␤-actin primer pair (sense: 5Ј-ctaaggccaaccgtgaaaag-3Ј and antisense: gccatctcttgctcgaagtc, 0.25 M final concentration of each) amplified a 311-bp product. Semiquantitative RT-PCR amplification was undertaken according to a well-established laboratory protocol (9, 14) . Briefly, Kir6.1 and SUR2 products were amplified for 30 cycles, whereas ␤-actin amplification was stopped after 20 cycles to remain in the linear phase (Fig. 2C) . Because ␤-actin amplification, even in the linear phase of amplification, remains stable under all test conditions (see agarose gels in Fig. 2, A and B) , Kir6.1 and SUR2B PCR products were normalized with the ␤-actin signal for each cDNA sample. RT-PCR products were finally separated on agarose gels, stained with ethidium bromide, and analyzed with the Typhoon Gel Imager, as described previously (9, 14) .
Sequencing. The 544-bp and 169-bp bands, obtained respectively with Kir6.1 and SUR2 primer pairs, were extracted from agarose gel with QIAEXII (Qiagen, Mississauga, Ontario, Canada) according to the manufacturer's instructions. The products were purified by filtration on Microcon-PCR filters (Amicon, Beverly, MA) and ligated in pGEMT-Easy vector (Promega, Madison, WI). The nucleotide sequence of the isolated clones was confirmed by sequencing at the Centre hospitalier de l'Université de Montréal (CHUM) sequencing facilities with an ABI Prism 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA).
Electrophysiology
Short-circuit current measurements in an Ussing chamber. Rat ATII cell monolayers (day 3 or 4) with high resistance (Ͼ1,200 ⍀⅐cm 2 ) and high Na ϩ transport rates were mounted in a heated (37°C) Ussing chamber and perfused on the apical and basolateral sides with warm physiological solution (containing in mM: 140 NaCl, 5 KCl, 10 TES, 1 MgCl 2, 1 CaCl2, and 10 glucose). The transepithelial potential difference was clamped to zero by an external voltage clamp amplifier (apical and basolateral sides of the monolayer connected via KCl agar-calomel half-cells and Ag-AgCl electrodes), and the resulting short-circuit current (I sc) was recorded continuously on a computer. Resistance was determined from the current needed to clamp voltage from 0 to 1 mV for 1 s every 10 s.
Statistics. Average values are given as means Ϯ SE, and n represents the number of experiments that were performed on at least four different animals.
RESULTS
Molecular Identity and Expression of K ATP Channels in Alveolar Epithelial Cells
The molecular identity of the lung K ATP channel subunits was investigated in alveolar cells. Different primer pairs, designed to specifically amplify rat Kir6.1, Kir6.2, SUR1, and SUR2, were used to generate PCR products from cDNAs of freshly isolated ATII cells (Fig. 1) . The Kir6.1 primer pair (see MATERIALS AND METHODS) amplified a ϳ1,200-to 1,300-bp product, which could correspond to full-length Kir6.1 (Fig.  1A ). In addition, the SUR2 primer pair amplified a PCR product that corresponded to the size expected (ϳ4.6 kb) for full-length SUR2A or SUR2B (Fig. 1D) . However, this primer pair could not discriminate between SUR2A and SUR2B (see MATERIALS AND METHODS) . No product could be detected with primers designed from Kir6.2 or SUR1 ( Fig. 1 , B and C). These results suggested that the alveolar K ATP channel could be formed from the Kir6.1 and SUR2 subunits.
It is well established that ATII cells progressively lose their phenotype in culture. For this reason, we decided to follow the expression of the Kir6.1 and SUR2 subunits from freshly isolated ATII cells (day 0) to ATII monolayers cultured for 1-4 days (time when electrophysiological experiments were performed). For this purpose, new primers were designed to amplify smaller PCR products for Kir6.1 and SUR2 to produce a more reliable semiquantitative protocol. For Kir6.1, the new primers (see MATERIALS AND METHODS) amplified, as expected, a 544-bp fragment. This 544-bp band was extracted, purified, and subcloned into pGEMT-Easy vector. Sequencing the insert confirmed 100% identity with cloned rat Kir6.1 (Ref. 30, GenBank NM017099). As represented in Fig. 2A , Kir6.1 expression decreased progressively from freshly isolated cells (day 0) to cells cultured for 2 days (78 Ϯ 2% decline between days 0 and 2, P Ͻ 0.001, n ϭ 4). Expression increased afterwards, on days 3 and 4 (44 Ϯ 10% increment between days 2 and 4, P Ͻ 0.025, n ϭ 4).
As detailed (in MATERIALS AND METHODS), the nucleotide sequences of SUR2A and SUR2B being identical, apart from an insertion in the 3Ј-end of the coding region of SUR2A, the primer pair used in Fig. 1D could therefore amplify the two SUR2 subunits. A new pair of PCR primers was designed to frame the 3Ј-end insert of SUR2A and amplify products of different size from either SUR2A or SUR2B (343 and 169 bp, respectively; see MATERIALS AND METHODS). As observed in Fig.  2B , only a 169-bp product could be amplified. Sequencing this PCR product confirmed 100% identity to the rat SUR2B subunit (Ref. 11, GenBank AB045281). The expression of this SUR2B subunit was then followed in primary cultured cells. The observed expression profile of SUR2B was similar to Kir6.1. Indeed, there was an initial 88 Ϯ 2% decrease (P Ͻ 0.001, n ϭ 6) between freshly isolated ATII cells (day 0) and cultured cells until day 2, followed by a 21 Ϯ 6% rise between days 2 and 4 (P Ͻ 0.025, n ϭ 6).
Evidence of K ATP , KvLQT1, and K Ca Channel Activities in Alveolar Epithelial Cells
ATII cells in primary culture formed tight epithelia with a high Na ϩ transport rate. Mean total I sc and transepithelial resistance, measured in the Ussing chamber, of ATII monolayers cultured for 3 or 4 days on permeable filters were 6.7 Ϯ 0.2 A/cm 2 and 1,372 Ϯ 84 ⍀⅐cm 2 , respectively (n ϭ 67). As K ATP subunits were detected in alveolar epithelial cells, we decided to explore the presence of K ATP activity in alveolar monolayers. It was observed that basolateral application of glibenclamide (100 M), an inhibitor of K ATP channels, reduced the I sc by 50 Ϯ 5% (n ϭ 7, P Ͻ 0.001, Table 1 ).
The activities of the two main K ϩ channels (KvLQT1 and K Ca ), described in nasal and lung epithelial cells, were also explored. The KvLQT1 channel was inhibited by clofilium. Basolateral application of clofilium (100 M) elicited 79 Ϯ 3% inhibition of total I sc (n ϭ 7, P Ͻ 0.001, Table 1 ). Charybdotoxin (200 nM), an inhibitor of K Ca channels (IK Ca or maxi-K Ca ), and iberiotoxin (100 nM), an inhibitor of maxi-K Ca channels, induced a smaller decrease of I sc (15 Ϯ 2%, P Ͻ 0.001, n ϭ 6, and 16 Ϯ 3%, P Ͻ 0.01, n ϭ 5, with charybdotoxin or iberiotoxin, respectively; Table 1 ). Clotrimazole (20 M, basolateral side), an inhibitor of the IK Ca channel subclass, reduced total I sc by 41 Ϯ 5% (n ϭ 6, P Ͻ 0.001, Table  1 ). Higher doses of clofilium, clotrimazole, and glibenclamide failed to increase the inhibitory effects (results not shown).
The decrease of I sc observed after basolateral application of these K ϩ channel inhibitors was relatively slow, with a maximum impact measured after 40 min of treatment (see glibenclamide outcome in Fig. 3B ). This suggests that the 15-79% I sc reduction induced by K ϩ channel inhibitors could be due, in part, to K ϩ channel suppression and subsequent depression of other pathways, such as Na ϩ or Cl Ϫ channels. We therefore decided to test the impact of K ϩ activity on Na ϩ and Cl Ϫ transport.
Role of the K ATP Channel in Na ϩ and Cl Ϫ Transport in Alveolar Cells
Effect of K ϩ channel inhibitors on Na ϩ transport. In alveolar epithelial monolayers, total I sc measured in the Ussing chamber (6.3 Ϯ 0.8 A/cm 2 ) was for the most part achieved by the apical ENaC channel (Fig. 3) . Indeed, application of the ENaC blocker amiloride (1 M, apical side) resulted in a sharp I sc decrease (i.e., 68 Ϯ 2% inhibition of total I sc , P Ͻ 0.001, n ϭ 27), reaching a stable value after 5 min. Amiloride also induced a small increase of transepithelial resistance (528 Ϯ 146 ⍀⅐cm 2 increment). The 5.61 Ϯ 0.25 A/cm 2 decline in I sc (Fig. 3A) corresponded to amiloride-sensitive current (I amil ). This response was stable over a 70-min period, since a second amiloride treatment induced a similar effect (5.83 Ϯ 1.01 A/cm 2 ; Fig.  3, A and D) . To test the effect of K ϩ channel activity on Na ϩ transport, we then compared the magnitude of I amil before and after treatment with K ϩ channel inhibitors. As reported previously (Table 1) , glibenclamide (100 M, basolateral side) progressively reduced total I sc (Fig. 3B ). Subsequent addition of amiloride (1 M, apical side) elicited additional I sc inhibition. The magnitude of I amil measured after K ATP inhibition by glibenclamide treatment was reduced by 54 Ϯ 6% (P Ͻ 0.001, n ϭ 7; Fig. 3, B and D) . To verify that glibenclamide specifically affected the K ATP channel, we tested apical glibenclamide treatment (100 M), which could potentially block apical CFTR channels. After a small decrease of total I sc (from 6.22 Ϯ 0.8 to 5.26 Ϯ 0.7, corresponding to a 13 Ϯ 4% decline, n ϭ 5), we verified that this treatment failed to reduce I amil (i.e., I amil of 3.69 Ϯ 0.5 and 3.42 Ϯ 0.4 before and after apical glibenclamide treatment, 5.4 Ϯ 3.6% diminution, not significant). The effects of KvLQT1 and K Ca inhibitors on I amil were also studied. A 40-min treatment with 100 M clofilium, the KvLQT1 channel blocker, reduced I amil by 74 Ϯ 3% (P Ͻ 0.001, n ϭ 7, Fig. 3D ). Charybdotoxin (200 nM), an inhibitor of IK Ca and maxi-K Ca channels, as well as iberiotoxin, the maxi-K Ca inhibitor, induced a small but significant decrease of I amil (i.e., 13 Ϯ 4% inhibition, P Ͻ 0.025, n ϭ 6, and 15 Ϯ 3%, P Ͻ 0.01, n ϭ 5, respectively), whereas IK Ca suppression with 20 M clotrimazole evoked a 37 Ϯ 6% reduction (P Ͻ 0.005, n ϭ 6, Fig. 3D) .
To determine the effect of concomitant blockage of the three classes of K ϩ channels (K ATP , KvLQT1, and K Ca ) on Na ϩ transport, glibenclamide, clofilium, and clotrimazole were also applied in combination. Comparison of Fig. 3B (glibenclamide alone) and 3C (combination of the three inhibitors) shows that the kinetics of inhibition of total I sc were faster in the presence of the three inhibitors. In addition, 20-min treatment with these inhibitors allowed a 86 Ϯ 1% reduction in I amil (n ϭ 5, P Ͻ 0.001), whereas 40 min were necessary to deplete I amil by 54, 74, or 37% with glibenclamide, clofilium, or clotrimazole alone, respectively (Fig. 3D) .
Various studies have shown that K ϩ channels (KvLQT1 and K Ca ) play a role in Cl Ϫ secretion in nasal and lung epithelial cells (for example, see 13, 16, 41, 42, 43, 50) . We, therefore, tested whether the K ATP channel could play a similar role in alveolar epithelial cells. 
The mean total short-circuit current (Isc, A/cm 2 ) of cultured epithelial alveolar monolayers was measured in the absence or presence of K ϩ channel inhibitors glibenclamide (Glib., 100 M), clofilium (Clofi., 100 M), charybdotoxin (Charybdo., 200 nM), clotrimazole (Clotrim., 20 M), and iberiotoxin (Iberio., 100 nM), which were applied at the basolateral side for 40 min. The charybdotoxin treatment induced a slight decrease of transepithelial resistance (267 Ϯ 86 ⍀⅐cm 2 , P Ͻ 0.05). The decreases of transepithelial resistance measured after the other treatments are nonsignificant: 46 Ϯ 109, 118 Ϯ 98, 180 Ϯ 179, 242 Ϯ 171 ⍀⅐cm 2 decrease with glibenclamide, clofilium, clotrimazole, and iberiotoxin, respectively. The glibenclamide-, clofilium-, charybdotoxin-, clotrimazole-, and iberiotoxin (inhibitor)-sensitive currents and Isc inhibition are also indicated. ATII monolayers were first treated with 1 M amiloride (apical side) to block ENaC. Forskolin (10 M), which increases intracellular cAMP (5), was then added to the basolateral side, since cAMP is a known activator of Cl Ϫ channels, including CFTR or Ca-activated Cl Ϫ channels (3). As observed in Fig. 4, after a (Fig. 5A) , as did inhibition of KvLQT1 by clofilium (Fig. 5B) or of K Ca by clotrimazole (Fig. 5C) .
Effect of the K ATP channel activator, pinacidil, on Na ϩ and Cl Ϫ transport. I amil was then measured after stimulation with the K ATP channel activator pinacidil. It was observed that this treatment increased I amil from 4.09 Ϯ 0.17 A/cm 2 (in the control condition) to 5.47 Ϯ 0.37 A/cm 2 (after 10-min treatment with 100 M pinacidil, i.e., 33 Ϯ 4% increment, P Ͻ 0.001, n ϭ 4, Fig. 6A ).
The amplitude of NPPB-sensitive Cl Ϫ current measured after forskolin stimulation was also compared in the presence and absence of 100 M pinacidil. A 10-min pretreatment with pinacidil increased forskolin-stimulated Cl Ϫ current by 35 Ϯ 8% (P Ͻ 0.01, n ϭ 6, Fig. 6B ).
DISCUSSION
The results presented in this study have allowed us to determine the molecular identity of K ATP channels (Kir6.1 plus SUR2B subunits) present in alveolar epithelial cells and to demonstrate their role in Na ϩ and Cl Ϫ transport in these cells. Indeed, K ATP channel inhibition by glibenclamide reduced 1) total I sc and 2) amiloride-sensitive Na ϩ current and 3) abolished Cl Ϫ current stimulation by forskolin in cultured ATII monolayers. Conversely, K ATP channel activation by pinacidil increased Na ϩ and Cl Ϫ transepithelial transport.
Molecular Identity and Expression of the Alveolar K ATP Channels
The use of PCR primers designed from cloned rat Kir6.1 and Kir 6.2, SUR1, 2A, and 2B subunits allowed us to amplify, from freshly isolated epithelial alveolar cells, PCR products for Kir6.1 and SUR2B, suggesting that the alveolar K ATP channel could be formed from these two subunits. Alkaline phosphatase staining showed that this final freshly isolated cell mix contained 86% of ATII cells. Most alkaline phosphatasenegative cells seemed to be macrophages. However, it is unlikely that the amplified signal came from these cells since K ATP channels appeared to be absent in macrophage (26) . In addition, the lungs were perfused by the pulmonary artery to remove most blood cells. However, minor contamination in the freshly isolated cell mix could not be excluded. Indeed, K ATP channels have been observed in lamprey red blood cells (38) . In leukocytes, Kir6.1 mRNA but not SUR mRNAs have been detected (57) . However, in culture, these blood cells are unlikely to be present in mRNA extracts of alveolar epithelial monolayers.
It has been demonstrated that ATII cells progressively change their phenotype in primary culture. In particular, they rapidly lose some specific characteristics, such as phosphatase alkaline activity (21), surfactant synthesis, and the presence of lamellar bodies. The cells also lose their cuboidal shape (49), to progressively gain a more flattened morphology and the expression of ATI markers, such as RTI40 (18) . In a previous study, we reported that CFTR expression decreased progressively in primary culture (Brochiero E, Dagenais A, Berthiaume Y, and Grygorczyk R, unpublished observations; Ref. 9). In fact, channel expression seemed related to culture conditions (Brochiero E, Dagenais A, Berthiaume Y, and Grygorczyk R, unpublished observations; Refs. 9, 32). We indeed observed that, on permeable filters, the level of CFTR and surfactant protein A (SP-A) expression remained detectable, even after 4 days of culture (Brochiero E, Dagenais A, Berthiaume Y, and Grygorczyk R, unpublished observations; Ref. 9). Because conditions for I sc measurements (with high currents and resistance) were optimal on alveolar cell monolayers cultured on filter for 3 or 4 days, we decided to verify if Kir6.1 and SUR2B mRNA, identified on freshly isolated cells, were still detectable in cultured monolayers. Conversely to the continuous decrease in SP-A and CFTR expression that we reported previously (9), we found here that Kir6.1 and SUR2B expression first decreased between days 0 and 2 and then rose surprisingly on days 3 and 4. Nevertheless, the estimated level of expression on day 4 remained lower than in freshly isolated cells. The similarity between the expression profile of Kir6.1 and SUR2B mRNA suggests that expression of the two different types of subunits forming the K ATP channel is modulated in parallel as a function of culture duration. In a recent study, Lee et al. (40) reported that Kir6.1, Kir6.2, SUR1, or SUR2 mRNA could not be detected in cultured rat alveolar epithelial cells. Differences in culture (different culture media) and RT-PCR (primers and annealing temperatures) conditions could explain the discrepancy. Most importantly, as we observed, K ATP expression varied with time of culture. In the study of Lee et al. (40) , RT-PCR experiments were performed on rat alveolar cells maintained in culture for 5-7 days, whereas Kir6.1 and SUR2B expression was followed in our work from freshly isolated alveolar cells to monolayers cultured for a maximum of 4 days. We intentionally chose the same culture period for the PCR and electrophysiological experiments, as days 3 and 4 are optimal (high current and resistance) for I sc measurements.
The Kir6.1 and SUR2B mRNA detection that we have reported here is consistent with the known organ distribution of Kir6 and SUR subunits. Indeed, Kir6.1 and SUR2B mRNAs are ubiquitously expressed, including in the lung, whereas Kir6.2 and SUR1 are predominantly expressed in pancreatic cells, and SUR2A in heart and skeletal muscle (28, 30, 31) . Although Kir6.1 and SUR2B mRNAs have been detected in whole lung extracts, our results are the first to demonstrate that the two subunits are present in alveolar epithelial cells.
Evidence of KvLQT1, K Ca , and K ATP Channel Activities in Epithelial Alveolar Cells
RT-PCR experiments suggested the presence of a K ATP channel in alveolar epithelial cells. However, the contribution of this channel to ion membrane transport in alveolar monolayers needed to be explored. In fact, a single study by Sakuma et al. (48) reported K ATP channel activity in the human lung. They established that YM934, a K ATP channel opener, increased potassium influx into the alveolar spaces. In this study, we now report that K ATP channel inhibition by 40-min basolateral treatment with glibenclamide reduced total I sc by 50%.
The basolateral effect of glibenclamide indicates that the K ATP channel could be located at the basolateral membrane of alveolar epithelial cells. Western blot and immunohistochemistry experiments are, however, required to confirm, at the protein level, the presence of the channel at the basolateral membrane.
The sensitivity of total I sc to basolateral glibenclamide suggests K ATP channel activity in epithelial alveolar monolayers under resting conditions. Such K ATP channel activity has been detected in various native cells with mM intracellular ATP concentrations. However, the sensitivity of K ATP channels to ATP measured in excised-patch experiments is in the micromolar range. Various hypotheses have been postulated to explain this complex paradox observed in several tissues expressing K ATP channels. For example, it has been observed that Mg-ADP reduced sensitivity to ATP, suggesting that the ATP/ ADP ratio could be more important than the ATP level to control K ATP activity. More recently, it has been shown that membrane phospholipids might reduce the channel's sensitivity to ATP into the physiological range (for review, see Ref.
2). It has also been suggested that the microenvironment in the vicinity of the membrane K ATP channel could influence its regulation (6, 51) . The spatial arrangement of proteins like adenylate kinases (AK), which convert ATP plus AMP into ADP, could also provide an effective phosphotransfer system to modulate the ATP/ADP ratio in the microenvironment of K ATP channels (20) . We previously identified AK3 protein from proximal tubules, which activated K ATP currents (7) .
Because KvLQT1 and K Ca channels are K ϩ channels generally described in nasal and lung epithelial cells, their activity was also investigated. The effect of K ATP , KvLQT1, and K Ca inhibitors on transepithelial transport was then compared.
We observed that KvLQT1 channel inhibition by clofilium considerably reduced total I sc (79% inhibition after 40 min). KvLQT1 channels have been reported in many airway epithelial cells, including human (43) and murine (41) nasal cells, murine trachea (25) , mouse ciliated epithelial cells of terminal bronchioles (15) , and Calu-3 cells (13) . In a previous study, Demolombe et al. (15) noted that a KvLQT1 antisense probe failed to stain alveoli in the mouse lung. Even if the level of KvLQT1 expression could be too low for in situ hybridization, we nevertheless detected its activity in alveolar monolayers.
Inhibition of total I sc by charybdotoxin (IK Ca and maxi-K Ca inhibitor, 15% inhibition), clotrimazole (IK Ca inhibitor, 41% inhibition), and iberiotoxin (maxi-K Ca inhibitor, 16% inhibition) revealed the presence of a third class of K ϩ channels (K Ca channels) in cultured alveolar epithelial cells. The magnitude of inhibition of total I sc was smaller with these inhibitors compared with that observed in the presence of glibenclamide or clofilium. In fact, K Ca channels could be only partially active in the resting condition with low intracellular calcium concentrations. Patch-clamp or PCR experiments are necessary to clearly define the identity (IK Ca -SK or maxi-K Ca -Slo1) of alveolar K Ca channels. The small-intermediate K Ca channel (IK Ca or SK4 channel), sensitive to clotrimazole and charybdotoxin, has been reported in the trachea and bronchi (13, 44, 55) . Nasal cells and the alveolar A549 cell line developed high K Ca conductance sensitive to charybdotoxin (maxi-K or Slo1 channel) (36, 37, 47) . Conversely, in a recent review, O'Grady and Lee (46) recorded as unpublished data that Slo1 mRNA could not be detected in adult rat alveolar epithelial cells.
However, their culture conditions and duration were not described. In fact, the clotrimazole and iberiotoxin sensitivity observed in our study suggests the presence of both IK Ca and maxi-K Ca activity.
The observed kinetics of I sc inhibition by any K ϩ channel inhibitors are slow (see Fig. 3 ). Our hypothesis was that the progressive I sc decline could be due to sequential events. Indeed, K ϩ current inhibition could be followed by changes in electrochemical gradients that will secondarily affect other ion transport, such as the Na ϩ or Cl Ϫ conductance. To test this hypothesis, we decided to investigate the effect of K ϩ channel inhibitors on Na ϩ and Cl Ϫ transport.
Role of the K ATP Channel in Na ϩ Transport
We noted that inhibition of K ATP , KvLQT1, and K Ca channels with glibenclamide, clofilium, and clotrimazole reduced amiloride-sensitive Na ϩ currents by 54, 74, and 37%, respectively. In addition, pinacidil, a K ATP channel activator, increased I amil significantly (33%).
A previous study (48) has shown that the K ATP channel opener YM934 augmented K ϩ transport and alveolar clearance in the human resected lung. In addition, it has been found that glibenclamide and amiloride blocked the increase of alveolar clearance stimulated by YM934, suggesting that K ATP and ENaC channels mediated this effect. In our study, we confirmed that K ATP channel activity could be related to Na ϩ transepithelial transport, since K ATP channel inhibitors and activators could respectively down-and upregulate amiloridesensitive Na ϩ current. The absence of effect with apical glibenclamide treatment on the Na ϩ transport confirmed that the reduction of I amil with basolateral glibenclamide was really secondary to K ATP inhibition and not to a nonspecific effect through CFTR channels.
Although several investigations have established a role for KvLQT1 channels in Cl Ϫ secretion in nasal and bronchial epithelial cells (13, 41, 42, 43) , a single study (25) recently demonstrated that KvLQT1 could play a role in Na ϩ absorption in the trachea. Our results underscore here that KvQT1 activity seems also related to Na ϩ transport in alveolar cells. It has been shown that both intermediate-and high-conductance K Ca channels are related to Cl Ϫ secretion (16, 42, 50) ; however, to the best of our knowledge, there is no evidence that these K Ca channels could play a role in Na ϩ transport in lung epithelial cells. Our study reveals, for the first time, that K Ca inhibition could affect Na ϩ transport in alveolar cells.
Nature of Forskolin-Stimulated Cl Ϫ Current
Forskolin raises cAMP levels by directly activating adenylate cyclase in a variety of tissues, including alveolar epithelial cells (5) . We observed that this cAMP increase progressively stimulated a Cl Ϫ current sensitive to NPPB in alveolar epithelial monolayers. The precise nature of Cl Ϫ channel(s) contributing to this current is still undetermined. In fact, in fetal alveolar cells, the CFTR channel has been frequently detected, and its role in Cl Ϫ secretion is well documented (39, 45, 52) . On the other hand, in the adult alveolar epithelium, a tissue involved principally in Na ϩ reabsorption, the presence and role of CFTR are still controversial (for review, see Ref. 46 ). Yet we have recently shown the presence of functional CFTR channels in freshly isolated adult ATII cells. Even reduced compared with freshly isolated cells, CFTR expression was still detectable in primary cultured ATII monolayers (9), suggesting that the observed forskolin-stimulated Cl Ϫ current could be mediated by CFTR. However, the kinetics of Cl Ϫ current activation (Fig. 4) were slower than those generally reported for CFTR-mediated currents (39) . The reduced number of CFTR channels in cultured monolayers could explain these slow kinetics of activation. Alternatively, forskolin may also indirectly stimulate other Cl Ϫ channels, like calciumactivated Cl Ϫ channels (3). Indeed, we observed that both apical glibenclamide (to block CFTR channels) and DIDS (a general inhibitor of Cl Ϫ channels without effect on CFTR) partially inhibit NPPB-sensitive, forskolin-stimulated Cl Ϫ current (unpublished data), indicating that CFTR as well as additional Cl Ϫ channels could be involved in this current. Interestingly, this Cl Ϫ conductance could play a physiological role in ion transport. More precisely, some studies have possibly implicated Cl Ϫ conductance in stimulation of Na ϩ transport by cAMP analogs or ␤-agonists as stated in a recent review (46) . In particular, recent work by Fang and coworkers (22) supports that hypothesis, since isoproterenol stimulation of fluid clearance was found to be abolished in CFTR knockout mice (Delta F508 mice).
Role of the K ATP Channel in cAMP-stimulated Cl Ϫ Transport
An interesting feature of the observed cAMP-stimulated Cl Ϫ current is its modulation by K ϩ inhibitors and activators. Indeed, we saw that K ATP , KvLQT1, or K Ca inhibition by basolateral glibenclamide, clofilium, or clotrimazole abolished forskolin-stimulated Cl Ϫ current, whereas K ATP activation significantly increased it. KvLQT1 has been previously shown to play a crucial role in Cl Ϫ secretion in bronchial and nasal cells (13, 41, 43) . Moreover, previous studies have related K Ca channels to Cl Ϫ secretion in the murine tracheal epithelium (16) and human nasal epithelium (50) . In this report, we note that a third class of K ϩ channels, K ATP , could be necessary for Cl Ϫ transport.
Concerted Role of K ϩ Channels
The slow inhibition kinetics of I sc observed in the presence of any of the three classes of K ϩ channel blockers (basolateral glibenclamide, clofilium, charybdotoxin, clotrimazole, or iberiotoxin) suggested a progressive effect, first on K ϩ current, which could secondarily affect other ion transports, such as Na ϩ and Cl Ϫ transepithelial transport. Indeed, a change in the electrochemical gradient following K ϩ channel inhibition could explain this effect on Na ϩ and Cl Ϫ currents. However, the coupling mechanism between basolateral K ϩ channels and apical Na ϩ or Cl Ϫ channels is still unknown, and various mechanisms are possible.
The kinetics of inhibition of total I sc and I amil were faster when these inhibitors were used in combination. This observation indicated that concomitant inhibition of K ATP , KvLQT1, and K Ca channels could probably modify the electrophysiological characteristics of the cell more rapidly, followed by faster secondary inhibition of Na ϩ transport. If the kinetics were modified in the presence of the three inhibitors, it should be noted that the maximal inhibition (86% in 20 min) was quite similar to that observed with one inhibitor (74% in 40 min for example, with clofilium). This observation suggests that inhibition of one type of K ϩ channel was sufficient to alter, albeit slowly, Na ϩ transport. These data suggest that the three different classes of K ϩ channels, K ATP , KvLQT1, and K Ca , could participate in the modulation of transepithelial transport in epithelial alveolar cells. Although this hypothesis is somewhat surprising, it is possible that a variety of K ϩ channels is needed to respond to the different physiological stimuli leading to changes in ion transport, since these channels have different electrophysiological characteristics (conductance and open probability) and regulatory mechanisms (ATP, cAMP, calcium).
In summary, our results identified the presence of a K ATP channel, formed from Kir6.1 and SUR2B subunits, in alveolar epithelial cells. This channel could play a significant role in epithelial lung physiology, since K ATP activity, in association with KvLQT1 and K Ca activities, seems related to Na ϩ and Cl Ϫ ion transport.
